Scalp Psoriasis

27 registered clinical trials studyying Scalp Psoriasis — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Daxxin Psoriasis Shampoo PMCF NCT06771648	Daxxin AB	N/A
Not Yet Recruiting	Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real) NCT06802848	Chongqing Genrix Biopharmaceutical Co., Ltd	—
Completed	Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Gen NCT05969223	AbbVie	Phase 4
Completed	A Demonstration of the Hair and Scalp Benefits of Duobrii in Scalp Psoriasis NCT05872256	Dermatology Consulting Services, PLLC	Phase 4
Completed	Comparison Of Efficacy Of Tazarotene 0.045% Vs Halobetasol Propionate 0.01% Lotion For Treatment of Scalp Psor NCT06015152	Jinnah Postgraduate Medical Centre	N/A
Completed	Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis NCT05272150	Janssen Research & Development, LLC	Phase 3
Completed	Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR) NCT05028582	Arcutis Biotherapeutics, Inc.	Phase 3
Completed	A Study of the Safety and Efficacy of UHE-105 Shampoo in Subjects With Scalp Psoriasis NCT04243486	Therapeutics, Inc.	Phase 2
Completed	Efficacy and Safety of Tildrakizumab in the Treatment of Scalp Psoriasis NCT03897088	Sun Pharmaceutical Industries Limited	Phase 3
Completed	Evaluate the Efficacy and Safety of Boroda Supramolecular Active Zinc in the Treatment of Scalp Psoriasis NCT04801433	Xijing Hospital	N/A
Completed	To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis NCT03880357	Sun Pharmaceutical Industries, Inc.	Phase 1
Completed	To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Suspension, 0.005%/0.064%, in the Treatm NCT03331523	Glenmark Pharmaceuticals Ltd. India	Phase 3
Completed	BE Study of Calcipotriene Hydrate and Betamethasone Dipropionate Topical Suspension in the Treatment of Scalp NCT03122353	Tolmar Inc.	Phase 1
Completed	Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product NCT02933502	Sun Pharmaceutical Industries, Inc.	Phase 2
Completed	Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis NCT02933866	Sun Pharmaceutical Industries, Inc.	Phase 3
Completed	Study to Evaluate Efficacy and Safety of the Topical Product in Patients With Mild to Severe Scalp Psoriasis NCT02932462	Sun Pharmaceutical Industries, Inc.	Phase 3
Unknown	Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) in the Treatment of Scalp Psoriasis NCT02749656	Siriraj Hospital	Phase 3
Completed	IL-17 Role in Variants of Psoriasis NCT02078297	Innovaderm Research Inc.	—
Completed	Parallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients NCT01914627	G. Pohl-Boskamp GmbH & Co. KG	Phase 2
Unknown	A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis NCT01558310	Paul Steven Yamauchi, MD, PhD	Phase 4
Completed	Efficacy and Safety of Xamiol® Gel Compared to Calcipotriol Scalp Solution in Patients With Scalp Psoriasis NCT01195831	LEO Pharma	Phase 3
Completed	Safety and Efficacy of LEO 80185 Gel in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis NCT01120223	LEO Pharma	Phase 2
Completed	Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasi NCT01083758	LEO Pharma	Phase 2
Completed	Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel) NCT01052467	LEO Pharma	—
Completed	Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of NCT00881868	Galderma R&D	Phase 4
Completed	Subject Preference for Scalp Psoriasis Treatment NCT00438399	Galderma R&D	Phase 3
Completed	Maintenance Effect of Clobex Shampoo on Participants With Moderate to Severe Scalp Psoriasis NCT00400725	Galderma R&D	Phase 3